Intraprostatic distribution and long term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer
A phase I-II study to evaluate gene mediated cytotoxic immunotherapy in newly diagnosed prostate cancer before radical prostatectomy was conducted in Monterrey, Mexico.
Main Authors: | Rojas-Martínez, Augusto, Manzanera, Andrea G., Sukin, Steven W., Esteban-María, Jacinto, González-Guerrero, Juan Francisco, Gomez-Guerra, Lauro, Garza-Guajardo, Raquel, Flores-Gutiérrez, Juan Pablo, Riojas, Guillermo Elizondo, Delgado-Enciso, Iván, Ortiz-López, Rocío, Aguilar, Laura K., Butler, E. Brian, Barrera-Saldaña, Hugo A., Aguilar-Cordova, Estuardo |
---|---|
Format: | Online |
Language: | English |
Published: |
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842423/ |
Similar Items
-
The Role of Intraprostatic Inflammation in the Acute Urinary Retention
by: Asgari, Seyed Alaeddin, et al.
Published: (2011) -
Therapeutic Endoscopic Ultrasonography: Intratumoral Injection for Pancreatic Adenocarcinoma
by: Shirley, Lawrence A., et al.
Published: (2013) -
Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy
by: Kumon, H, et al.
Published: (2016) -
Masthead: (Adv. Sci. 9/2016)
Published: (2016) -
Contents: (Adv. Sci. 9/2016)
Published: (2016)